# UPTRAVI

NDC: 66215-616
Generic name: Selexipag
Labeler / Manufacturer: Actelion Pharmaceuticals US, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20151221

FDA application: NDA207947

## Active ingredients

- SELEXIPAG: 1600 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66215-616"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66215-616
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7a23b87-f892-4e2c-8e2e-ebf841220f90